These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 29044941)

  • 1. Clinical significance of changes in systemic inflammatory markers and carcinoembryonic antigen levels in predicting metastatic colorectal cancer prognosis and chemotherapy response.
    Kim IH; Lee JE; Yang JH; Jeong JW; Ro S; Lee MA
    Asia Pac J Clin Oncol; 2018 Jun; 14(3):239-246. PubMed ID: 29044941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer.
    Chua W; Charles KA; Baracos VE; Clarke SJ
    Br J Cancer; 2011 Apr; 104(8):1288-95. PubMed ID: 21448173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palliative primary tumor resection provides survival benefits for the patients with metastatic colorectal cancer and low circulating levels of dehydrogenase and carcinoembryonic antigen.
    He WZ; Rong YM; Jiang C; Liao FX; Yin CX; Guo GF; Qiu HJ; Zhang B; Xia LP
    Chin J Cancer; 2016 Jun; 35(1):58. PubMed ID: 27357402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microenvironment, systemic inflammatory response and tumor markers considering consensus molecular subtypes of colorectal cancer.
    Jakab A; Patai ÁV; Darvas M; Tormássi-Bély K; Micsik T
    Pathol Oncol Res; 2024; 30():1611574. PubMed ID: 38645565
    [No Abstract]   [Full Text] [Related]  

  • 5. Key Prognostic Factors Create a Composite Risk Score to Stratify Patients into High- and Low-Treatment Benefit Groups: A Multicenter, Retrospective Data Analysis of 84 Metastatic Colorectal Cancer Patients Treated with Regorafenib as Part of the CORRECT and CONSIGN Trials.
    Zöhrlaut LK; Karthaus M; Vehling-Kaiser U; von Kunhardt L; Stintzing S; Heinemann V; von Einem JC
    Oncol Res Treat; 2023; 46(9):348-361. PubMed ID: 37607525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated serum homocysteine levels associated with poor recurrence-free and overall survival in patients with colorectal cancer.
    Xie H; Wei L; Wang Q; Tang S; Gan J
    Sci Rep; 2024 May; 14(1):10057. PubMed ID: 38698172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of CYFRA 21-1 and CEA as prognostic and predictive markers in locally advanced and metastatic gastric carcinoma.
    Gopal V; Nisha Y; Ganesan P; Kayal S; Bobby Z; Adithan S; Penumadu P; Ramakrishnalay VP; Bandlamudi BP; Bahttacharjee A; Dahagama S; Dubashi B
    J Cancer Res Ther; 2024 Jan; ():. PubMed ID: 38261458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The predicting roles of carcinoembryonic antigen and its underlying mechanism in the progression of coronavirus disease 2019.
    Huang R; Meng T; Zha Q; Cheng K; Zhou X; Zheng J; Zhang D; Liu R
    Crit Care; 2021 Jul; 25(1):234. PubMed ID: 34217339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic role of serum carcinoembryonic antigen in patients receiving liver resection for colorectal cancer liver metastasis: A meta-analysis.
    Tang F; Huang CW; Tang ZH; Lu SL; Bai T; Huang Q; Li XZ; Zhang B; Wu FX
    World J Gastrointest Surg; 2023 Dec; 15(12):2890-2906. PubMed ID: 38222018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudoprogression during treatment with pembrolizumab followed by rechallenge with chemotherapy in metastatic colorectal cancer: A case report.
    Trabjerg ND; Rask C; Jensen LH; Hansen TF
    Clin Case Rep; 2019 Jul; 7(7):1445-1449. PubMed ID: 31360509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring Metastatic Colorectal Cancer Progression According to Reactive Oxygen Metabolite Derivative Levels.
    Sawai K; Goi T; Kimura Y; Koneri K
    Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers in advanced colorectal cancer: challenges in translating clinical research into practice.
    Lemech C; Arkenau HT
    Cancers (Basel); 2011 Apr; 3(2):1844-60. PubMed ID: 24212785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case Report: CEA Elevation Can Be a Marker of Increased Inflammation During Treatment with Oxaliplatin.
    Kerr D; Laber D; Visweshwar N; Jaglal M
    Anticancer Res; 2018 Mar; 38(3):1711-1713. PubMed ID: 29491106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of CD44v9-Expressing Cancer Stem Cells in Circulating Tumor Cells and Effects of Carcinoembryonic Antigen Levels on the Prognosis of Colorectal Cancer.
    Sawai K; Goi T; Kimura Y; Koneri K
    Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic monitoring of carcinoembryonic antigen, CA19-9 and inflammation-based indices in patients with advanced colorectal cancer undergoing chemotherapy.
    Manojlovic N; Savic G; Nikolic B; Rancic N
    World J Clin Cases; 2022 Jan; 10(3):899-918. PubMed ID: 35127905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative carcinoembryonic antigen (CEA) levels predict outcomes after resection of colorectal cancer in patients with normal preoperative CEA levels.
    Zhang C; Zheng W; Lv Y; Shan L; Xu D; Pan Y; Zhu H; Qi H
    Transl Cancer Res; 2020 Jan; 9(1):111-118. PubMed ID: 35117164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Systemic Inflammatory Reaction in Female Genital Organ Malignancies - State of the Art.
    Mleko M; Pitynski K; Pluta E; Czerw A; Sygit K; Karakiewicz B; Banas T
    Cancer Manag Res; 2021; 13():5491-5508. PubMed ID: 34276227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The platelet to lymphocyte ratio is a potential inflammatory marker predicting the effects of adjuvant chemotherapy in patients with stage II colorectal cancer.
    Fu Y; Chen X; Song Y; Huang X; Chen Q; Lv X; Gao P; Wang Z
    BMC Cancer; 2021 Jul; 21(1):792. PubMed ID: 34238262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex disparities in vitamin D status and the impact on systemic inflammation and survival in rectal cancer.
    Abrahamsson H; Meltzer S; Hagen VN; Johansen C; Bousquet PA; Redalen KR; Ree AH
    BMC Cancer; 2021 May; 21(1):535. PubMed ID: 33975557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Review of Colorectal Cancer in Terms of Epidemiology, Risk Factors, Development, Symptoms and Diagnosis.
    Sawicki T; Ruszkowska M; Danielewicz A; Niedźwiedzka E; Arłukowicz T; Przybyłowicz KE
    Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33922197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.